View in EDS HTML Full Text PDF Full Text

Temozolomide based treatment in glioblastoma: 6 vs. 12 months.

Saved in:

Bibliographic Details
Title:	Temozolomide based treatment in glioblastoma: 6 vs. 12 months.
Authors:	Fasano, Morena¹ (AUTHOR) morena.fasano@unicampania.it, Pirozzi, Mario¹ (AUTHOR), De Falco, Vincenzo² (AUTHOR), Miceli, Chiara Carmen¹ (AUTHOR), Farese, Stefano¹ (AUTHOR), Zotta, Alessia¹ (AUTHOR), Famiglietti, Vincenzo¹ (AUTHOR), Vitale, Pasquale² (AUTHOR), Di Giovanni, Ilaria² (AUTHOR), Brancati, Christian² (AUTHOR), Carfora, Vincenzo³ (AUTHOR), Solari, Domenico⁴ (AUTHOR), Somma, Teresa⁴ (AUTHOR), Cavallo, Luigi Maria⁴ (AUTHOR), Cappabianca, Paolo⁴ (AUTHOR), Conson, Manuel⁵ (AUTHOR), Pacelli, Roberto⁵ (AUTHOR), Ciardiello, Fortunato¹ (AUTHOR), Addeo, Raffaele² (AUTHOR)
Source:	Oncology Letters. Sep2024, Vol. 28 Issue 3, pN.PAG-N.PAG. 1p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Be the first to leave a comment!